DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 06 · Volume 51 · November 2018 DOI: 10.1055/s-008-41776

Erratum

  • e3
    Vlček, Přemysl; Polák, Jakub; Brunovský, Martin; Horáček, Jiří:

    Correction: Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications

    • Review

  • 229
    Vlček, Přemysl; Polák, Jakub; Brunovský, Martin; Horáček, Jiří:

    Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications

  • 243
    Proebstl, Lisa; Kamp, Felicia; Koller, Gabi; Soyka, Michael:

    Cognitive Deficits in Methamphetamine Users: How Strong is The Evidence?

    • Original Paper

  • 251
    Dembler-Stamm, Theresa; Fiebig, Jana; Heinz, Andreas; Gallinat, Jürgen:

    Sexual Dysfunction in Unmedicated Patients with Schizophrenia and in Healthy Controls

  • 257
    Miclea, Andrei; Miclea, Marius; Pistor, Maximilian; Stegmayer, Katharina; Hoepner, Robert:

    Intramuscular Testosterone Supplementation Ameliorates Depression in Hypogonadal Men: A Retrospective Study in an Outpatient Department

    Supporting Information (PDF)
  • 263
    Modarresi, Atieh; Sayyah, Mehdi; Razooghi, Setareh; Eslami, Kaveh; Javadi, Mohammadreza; Kouti, Leila:

    Memantine Augmentation Improves Symptoms in Serotonin Reuptake Inhibitor-Refractory Obsessive-Compulsive Disorder: A Randomized Controlled Trial

    • Letter to the Editor

  • 270
    Baldelli, Sara; Clementi, Emilio; Cattaneo, Dario:

    Can We Rely on AGNP Therapeutic Targets Also For LAI Antipsychotics?